Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin B9 studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin B9Vitamin B9 (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Case 16% per SD change Improvement Relative Risk Vitamin B9  Deschasaux-Tanguy et al.  Prophylaxis Does vitamin B9 reduce COVID-19 infections? Retrospective 7,766 patients in France Fewer cases with vitamin B9 (p=0.02) c19early.org Deschasaux-Tanguy et al., BMC Medicine, Nov 2021 Favors vitamin B9 Favors control

Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort

Deschasaux-Tanguy et al., BMC Medicine, doi:10.1186/s12916-021-02168-1
Nov 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Analysis of 7,766 adults in France, showing higher intakes of vitamin C, folate, vitamin K, dietary fibre, and fruit and vegetables associated with lower seropositivity.
Study covers vitamin B9, vitamin C, and diet.
risk of case, 16.0% lower, OR 0.84, p = 0.02, RR approximated with OR, per standard deviation change.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Deschasaux-Tanguy et al., 30 Nov 2021, retrospective, France, peer-reviewed, 95 authors.
This PaperVitamin B9All
Nutritional risk factors for SARS-CoV-2 infection: prospective study from the NutriNet-Sante ´cohort
Mathilde Touvier, M Deschasaux-Tanguy, L Bourhis, N Druesne-Pecollo, Y Esseddik, P Galan, S Hercberg, X De Lamballerie, F Carrat
17.3% in men; 35.8% and 18.4% in women) and 10.3% to injuries (4.9% among people aged 65 or more at time of death; 34.5% among people aged 25-44). Approximately 27% of the deaths registered were IDDs, representing approximately 1.8 million YLLs. Conclusions: These preliminary results confirm the importance of YLLs as a metric to target preventive strategies according to age. Moreover, by quantifying IDDs, we highlight that data gaps are important even in settings with highly developed health information systems. Next steps include applying an IDD redistribution methodology, aspirational life table and computing subnational YLLs. The French collaborative initiative should address those gaps and propose national and subnational burden metrics in the following months. Key messages: Methodological and data requirements to compute YLLs constitute a challenge even in settings with developed health information systems, highlighting the need of national institutional collaborations. Highlight data gaps in terms of ill-defined deaths in mortality database.
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit